“…Inflammatory reactions have been recognized as common phenomena involved in cardiac ischaemia and failure, atherosclerosis, diabetes and its cardiovascular complications. The biomarkers of pro‐inflammatory cytokines, ET‐1, NADPH oxidase, leptin, ROS, matrix metalloproteinases (MMPs) and Cx43, play roles in these lesions in diabetic complications (cardiomyopathy, nephropathy and orchidopathy), as well as in rheumatic arthritis and osteoarthritis [27–30] . Therefore, the anti‐inflammatory activity of rhein and argirein is potentially equal in alleviating diabetic insults in these aforementioned disorders, and in fact, diabetic nephropathy in streptozotocin‐injected rats was attenuated by argirein significantly [22] …”